HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hitoshi Yoshiji Selected Research

Fibrosis (Cirrhosis)

3/2024Tofogliflozin Delays Portal Hypertension and Hepatic Fibrosis by Inhibiting Sinusoidal Capillarization in Cirrhotic Rats.
1/2024Profiles associated with significant hepatic fibrosis consisting of alanine aminotransferase >30 U/L, exercise habits, and metabolic dysfunction-associated steatotic liver disease.
1/2024VWF/ADAMTS13 Ratio as a Potential Predictive Biomarker for Acute Kidney Injury Onset in Cirrhosis.
12/2023Vitamin D deficiency exacerbates alcohol-related liver injury via gut barrier disruption and hepatic overload of endotoxin.
12/2023Posttreatment liver function, but not baseline liver function stratifies patient survival after direct-acting antiviral treatment in decompensated cirrhosis with hepatitis C virus.
11/2023Aspartate aminotransferase to platelet ratio index has utility as a biomarker of COVID-19 severity in patients with nonalcoholic fatty liver disease.
10/2023Effects of entecavir and tenofovir alafenamide fumarate treatment on renal function in Japanese elderly patients with chronic hepatitis B.
7/2023Efficacy of Serum Ferritin-Zinc Ratio for Predicting Advanced Liver Fibrosis in Patients with Autoimmune Hepatitis.
5/2023Changes in Coagulation and Fibrinolytic Factors in Patients With Cirrhotic Refractory Ascites Undergoing Cell-free and Concentrated Ascites Reinfusion Therapy: A Retrospective Observational Study in Japan.
4/2023A Combination of an Angiotensin II Receptor and a Neprilysin Inhibitor Attenuates Liver Fibrosis by Preventing Hepatic Stellate Cell Activation.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hitoshi Yoshiji Research Topics

Disease

78Liver Cirrhosis (Hepatic Cirrhosis)
03/2024 - 07/2002
74Fibrosis (Cirrhosis)
03/2024 - 07/2002
52Hepatocellular Carcinoma (Hepatoma)
04/2024 - 04/2002
52Neoplasms (Cancer)
04/2024 - 03/2002
21Liver Diseases (Liver Disease)
01/2024 - 09/2004
20Fatty Liver
12/2023 - 10/2006
15Alcoholic Fatty Liver
10/2022 - 06/2007
14Non-alcoholic Fatty Liver Disease
11/2023 - 10/2006
14Infections
12/2022 - 05/2013
13Ascites
06/2023 - 02/2017
13Carcinogenesis
03/2020 - 07/2002
11Inflammation (Inflammations)
12/2023 - 11/2009
10Chronic Hepatitis C
10/2022 - 02/2005
9Hemorrhage
01/2023 - 11/2005
9Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
12/2022 - 01/2017
9Hepatic Encephalopathy
03/2022 - 12/2017
9Insulin Resistance
08/2020 - 01/2009
7Sarcopenia
12/2023 - 01/2020
6Thrombosis (Thrombus)
02/2024 - 08/2017
6Chronic Hepatitis (Chronic Active Hepatitis)
10/2023 - 10/2004
6Hyperammonemia
08/2022 - 12/2017
6Muscle Cramp (Cramp)
12/2020 - 12/2018
5Cholangitis
04/2025 - 02/2018
5Thrombocytopenia (Thrombopenia)
11/2023 - 01/2006
5Alcoholic Liver Diseases (Alcoholic Liver Disease)
12/2021 - 04/2011
4COVID-19
04/2025 - 06/2022
4Portal Hypertension
03/2024 - 01/2015
4Thrombophilia
02/2024 - 05/2019
4Atrophy
12/2023 - 12/2021
4Chronic Hepatitis B
10/2023 - 09/2017
4Acute-On-Chronic Liver Failure
01/2023 - 05/2020
4Liver Neoplasms (Liver Cancer)
01/2023 - 12/2014
4Cholangiocarcinoma
01/2023 - 08/2013
4Liver Failure
10/2022 - 10/2011

Drug/Important Bio-Agent (IBA)

23Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2023 - 03/2002
22Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2012 - 03/2002
18Biomarkers (Surrogate Marker)IBA
02/2024 - 07/2003
18Amino AcidsFDA Link
10/2023 - 07/2002
18InterferonsIBA
10/2022 - 02/2005
17EndotoxinsIBA
12/2023 - 02/2010
16Choline (Choline Chloride)IBA
12/2023 - 07/2002
15Proteins (Proteins, Gene)FDA Link
12/2023 - 10/2002
13von Willebrand FactorIBA
02/2024 - 11/2006
13CDAA (Randox)IBA
10/2022 - 07/2002
13CytokinesIBA
08/2022 - 05/2006
11Messenger RNA (mRNA)IBA
05/2023 - 04/2002
10LipopolysaccharidesIBA
04/2024 - 08/2017
10Angiotensin IIIBA
12/2023 - 09/2003
10Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
08/2010 - 03/2002
9EnzymesIBA
02/2024 - 07/2002
9Ursodeoxycholic Acid (Urso)FDA LinkGeneric
02/2024 - 02/2016
9Losartan (Cozaar)FDA LinkGeneric
12/2023 - 05/2009
9Antiviral Agents (Antivirals)IBA
12/2023 - 01/2017
9PerindoprilFDA LinkGeneric
11/2006 - 03/2002
8Aspartate Aminotransferases (Aspartate Transaminase)IBA
11/2023 - 09/2017
8Rifaximin (L 105)FDA Link
10/2022 - 12/2017
8Angiotensin II Type 1 Receptor BlockersIBA
01/2022 - 05/2009
8CollagenIBA
10/2020 - 07/2002
7Carbon Tetrachloride (Tetrachloromethane)IBA
03/2024 - 01/2017
7TolvaptanFDA Link
06/2023 - 02/2017
7DiureticsIBA
06/2023 - 02/2017
7AntigensIBA
01/2023 - 06/2008
7Sorafenib (BAY 43-9006)FDA Link
10/2022 - 05/2012
7Anti-Bacterial Agents (Antibiotics)IBA
12/2021 - 06/2011
7Branched-Chain Amino AcidsIBA
12/2021 - 01/2009
7Glucose (Dextrose)FDA LinkGeneric
03/2020 - 01/2006
7Glutathione Transferase (Glutathione S-Transferase)IBA
06/2018 - 07/2003
6Angiotensin Receptor AntagonistsIBA
12/2023 - 07/2011
6Serum AlbuminIBA
11/2023 - 01/2018
6AlbuminsIBA
06/2023 - 01/2017
6Toll-Like Receptor 4IBA
10/2022 - 11/2008
6Therapeutic UsesIBA
12/2020 - 01/2003
6Tissue Inhibitor of Metalloproteinase-1IBA
11/2006 - 10/2002
5lenvatinibIBA
04/2024 - 01/2021
5Interleukin-8 (Interleukin 8)IBA
04/2024 - 07/2005
5Alanine Transaminase (SGPT)IBA
01/2024 - 11/2006
5ZincIBA
07/2023 - 06/2021
5BilirubinIBA
10/2022 - 05/2012
5Transforming Growth Factor beta (TGF-beta)IBA
12/2016 - 05/2006
5Vitamin KFDA Link
05/2011 - 01/2007
4Metalloproteases (Metalloproteinases)IBA
02/2024 - 06/2008
4ThrombospondinsIBA
02/2024 - 06/2008
4Hyaluronic Acid (Hyaluronan)IBA
12/2023 - 08/2020
4lusutrombopagIBA
11/2023 - 01/2020
4Vasopressin Receptors (Arginine Vasopressin Receptor)IBA
06/2023 - 11/2006
4Hydroxyproline (4 Hydroxyproline)IBA
04/2023 - 07/2002
4Carrier Proteins (Binding Protein)IBA
10/2021 - 09/2017
4RNA (Ribonucleic Acid)IBA
07/2021 - 08/2005
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2021 - 11/2008
4Prednisolone (Predate)FDA LinkGeneric
01/2021 - 01/2018
4Insulin (Novolin)FDA Link
04/2020 - 01/2006
4Ribavirin (Virazole)FDA LinkGeneric
01/2019 - 01/2006
4Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
09/2017 - 03/2002
4AldosteroneIBA
08/2017 - 05/2010

Therapy/Procedure

48Therapeutics
12/2023 - 03/2002
11Drug Therapy (Chemotherapy)
01/2023 - 12/2014
8Oral Administration
10/2022 - 05/2005
6Chemoprevention
10/2014 - 11/2004
5Stents
02/2024 - 02/2019
4Liver Transplantation
10/2022 - 03/2011